DOI QR코드

DOI QR Code

Impact of the COVID-19 Pandemic on Gastric Cancer Screening in South Korea: Results From the Korean National Cancer Screening Survey (2017-2021)

  • Lee, Kyeongmin (Graduate School of Cancer Science and Policy, National Cancer Center) ;
  • Suh, Mina (National Cancer Center, National Cancer Control Institute) ;
  • Jun, Jae Kwan (National Cancer Center, National Cancer Control Institute) ;
  • Choi, Kui Son (Graduate School of Cancer Science and Policy, National Cancer Center)
  • Received : 2022.10.11
  • Accepted : 2022.10.24
  • Published : 2022.10.31

Abstract

Purpose: The coronavirus disease 2019 (COVID-19) pandemic has significantly disrupted cancer screening services worldwide. We aimed to measure the impact of COVID-19 on gastric cancer screening rates based on age, sex, household income, and residential area. Materials and Methods: We analyzed data from the Korean National Cancer Screening Survey from 2017 to 2021 for adults aged 40-74 years. We evaluated the gastric cancer screening rate within two years in accordance with the National Cancer Screening Program protocol recommendations and that within the previous year. We compared the trends in the pre- and post-COVID-19 outbreak periods. Results: Before the COVID-19 outbreak, there was little change in the gastric cancer screening rates until 2019. After the COVID-19 outbreak, the screening rate as per recommendation decreased from 70.8% in 2019 to 68.9% in 2020 and that for one year decreased from 32.7% in 2019 to 27.2% in 2020. However, as the COVID-19 pandemic continued after 2020, both gastric cancer screening rates as per recommendations and for one year rebounded. Although a similar trend was observed for the upper endoscopy screening rate, the upper gastrointestinal series screening rate decreased from 7.8% in 2020 to 3.1% in 2021. During the pandemic, the screening rate decreased among younger adults (40-49), those residing in metropolitan regions, and those with high incomes. Conclusions: Despite a decline in gastric cancer screening rate during the COVID-19 pandemic, the rate surged in 2021. Further studies are needed to estimate the impact of cancer screening delays on future cancer-related mortalities.

Keywords

Acknowledgement

This study was supported by the Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (#2210772).

References

  1. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol 2019;14:26-38.
  2. Suh YS, Yang HK. Screening and early detection of gastric cancer: east versus west. Surg Clin North Am 2015;95:1053-1066. https://doi.org/10.1016/j.suc.2015.05.012
  3. Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology 2017;152:1319-1328.e7. https://doi.org/10.1053/j.gastro.2017.01.029
  4. Luu XQ, Lee K, Jun JK, Suh M, Jung KW, Choi KS. Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean National Cancer Screening Program. J Gastroenterol 2022;57:464-475. https://doi.org/10.1007/s00535-022-01878-4
  5. Park SH, Kang MJ, Yun EH, Jung KW. Epidemiology of gastric cancer in Korea: trends in incidence and survival based on Korea Central Cancer Registry data (1999-2019). J Gastric Cancer 2022;22:160-168. https://doi.org/10.5230/jgc.2022.22.e21
  6. Information Committee of the Korean Gastric Cancer Association. Korean Gastric Cancer Association-led nationwide survey on surgically treated gastric cancers in 2019. J Gastric Cancer 2021;21:221-235. https://doi.org/10.5230/jgc.2021.21.e27
  7. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020;91:157-160.
  8. World Health Organization. Coronavirus disease (COVID-19): how is it transmitted? [Internet]. Geneva: World Health Organization; 2021 [cited 2022 Sep 12]. Available from: https://www.who.int/news-room/ questions-and-answers/item/coronavirus-disease-covid-19-how-is-it-transmitted.
  9. Brauner JM, Mindermann S, Sharma M, Johnston D, Salvatier J, Gavenciak T, et al. Inferring the effectiveness of government interventions against COVID-19. Science 2021;371:eabd9338. https://doi.org/10.1126/science.abd9338
  10. Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nat Can 2020;1:565-567. https://doi.org/10.1038/s43018-020-0074-y
  11. Epic Research. Delayed cancer screenings-a second look [Internet]. 2020 [cited 2022 Sep 20]. Available from: https://epicresearch.org/articles/delayed-cancer-screenings-a-second-look/.
  12. Ricciardiello L, Ferrari C, Cameletti M, Gaianill F, Buttitta F, Bazzoli F, et al. Impact of SARS-CoV-2 pandemic on colorectal cancer screening delay: effect on stage shift and increased mortality. Clin Gastroenterol Hepatol 2021;19:1410-1417.e9. https://doi.org/10.1016/j.cgh.2020.09.008
  13. Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 2020;21:1023-1034. https://doi.org/10.1016/S1470-2045(20)30388-0
  14. Sharpless NE. COVID-19 and Cancer. Washington, D.C.: American Association for the Advancement of Science; 2020:1290.
  15. Lai A, Pasea L, Banerjee A, Denaxas S, Katsoulis M, Chang WH, et al. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. medRxiv; 2020.
  16. Lee JB, Jung M, Kim JH, Kim BH, Kim Y, Kim YS, et al. Guidelines for cancer care during the COVID-19 pandemic in South Korea. Cancer Res Treat 2021;53:323-329. https://doi.org/10.4143/crt.2020.1256
  17. Dinmohamed AG, Visser O, Verhoeven RH, Louwman MW, van Nederveen FH, Willems SM, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol 2020;21:750-751. https://doi.org/10.1016/S1470-2045(20)30265-5
  18. Rees CJ, East JE, Oppong K, Veitch A, McAlindon M, Anderson J, et al. Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: guidance from the British Society of Gastroenterology. Clin Med (Lond) 2020;20:352-358.
  19. Suh M, Choi KS, Lee YY, Park B, Jun JK; Cancer Screening in Korea. Cancer screening in Korea, 2012: results from the Korean National Cancer Screening Survey. Asian Pac J Cancer Prev 2013;14:6459-6463. https://doi.org/10.7314/APJCP.2013.14.11.6459
  20. Battisti F, Falini P, Gorini G, Sassoli de Bianchi P, Armaroli P, Giubilato P, et al. Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses. Ann Ist Super Sanita 2022;58:16-24.
  21. Park H, Seo SH, Park JH, Yoo SH, Keam B, Shin A. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea. Epidemiol Health 2022;44:e2022053. https://doi.org/10.4178/epih.e2022053
  22. Ministry of Health and Welfare (KR). South Korea announces the roadmap for gradual return to normal (10.29) [Internet]. Sejong: Ministry of Health and Welfare; 2022 [cited 2022 Sep 27]. Available from: http://ncov.mohw. go.kr/en/tcmBoardView.do?brdId=12&brdGubun=125&dataGubun=&ncvContSeq=368308&contSeq=368308& board_id=1365&gubun=.
  23. Ryu JE, Choi E, Lee K, Jun JK, Suh M, Jung KW, et al. Trends in the performance of the Korean National Cancer Screening Program for gastric cancer from 2007 to 2016. Cancer Res Treat 2022;54:842-849. https://doi.org/10.4143/crt.2021.482
  24. Choi KS, Jun JK, Suh M, Park B, Noh DK, Song SH, et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea. Br J Cancer 2015;112:608-612. https://doi.org/10.1038/bjc.2014.608
  25. Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol 2021;7:878-884. https://doi.org/10.1001/jamaoncol.2021.0884
  26. OECD. Household Income in Metropolitan Areas 2016. Paris: OECD; 2016.
  27. DeGroff A, Miller J, Sharma K, Sun J, Helsel W, Kammerer W, et al. COVID-19 impact on screening test volume through the national breast and cervical cancer early detection program, January-June 2020, in the United States. Prev Med 2021;151:106559. https://doi.org/10.1016/j.ypmed.2021.106559
  28. Seong H, Hyun HJ, Yun JG, Noh JY, Cheong HJ, Kim WJ, et al. Comparison of the second and third waves of the COVID-19 pandemic in South Korea: importance of early public health intervention. Int J Infect Dis 2021;104:742-745. https://doi.org/10.1016/j.ijid.2021.02.004